Quarterly report pursuant to Section 13 or 15(d)

Subsequent Events

v2.4.1.9
Subsequent Events
3 Months Ended
Nov. 30, 2014
Subsequent Events [Text Block]
14.

Subsequent Events


  1.

On November 26, 2014 a Purchase and Sale Agreement was executed into between Lexaria Corporation, and Cloudstream Belmont Lake, LP for the purchase and sale of oil and gas working interests, net revenue interests and other interests in Belmont Lake, Mississippi for total consideration of $1,400,000. On December 5, 2014 the Lexaria Corporation closed the sale of Belmont Lake with Cloudstream Belmont Lake, LP. All outstanding debts were repaid in full through giving Lexaria total net proceeds of $721,807.

     
  2.

On December 12, 2014, the Company signed an extension on an amended Preliminary Lease Agreement and Extension of LOI, that was first executed on April 10, 2014 on behalf of Lexaria CanPharm Corp. - a wholly owned subsidiary of Lexaria, and Enertopia Corporation(Lessee) and Mr. Jeff Paikin of 1475714 Ontario Inc. (Lessor) sets out the Lessee’s and Lessor’s shared intent to enter into a lease agreement (the “Lease”) for warehouse space (the “Leased Premises”) in the building located at Burlington, Ontario (the “Building”).

     
  3.

On December 1, 2014, the Company executed a new consulting agreement with the CEO of the Company with consulting services being $10,000 per month plus GST.

     
  4.

On December 1, 2014, the Company executed a new consulting agreement with the CFO of the Company with consulting services being CAD$7,500 per month plus GST.

     
  5.

On December 12, 2014, the Company issued 119,047 common shares to Michelle Reillo as per the terms of the ViPova Tea LLC Operating Agreement.

     
  6.

On December 12, 2014, the Company issued 119,047 common shares to Marian Washington as per the terms of the Vipova Tea LLC Operating Agreement.

     
  7.

On December 22, 2014, the Company executed a new executive management consulting agreement with Thomas Ihrke with consulting services being US$3,000 per month.

     
  8.

On December 22, 2014, the Company granted 1,425,000 stock options to directors, officers and consultant of the Company with an exercise price of $0.11, expiring December 22, 2019.